Literature DB >> 19234182

Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Sarah F Andrews1, David J Rawlings.   

Abstract

The signaling programs that enforce negative selection in early transitional (T1) B cells in response to BCR engagement remain poorly defined. We conducted a comprehensive comparison of BCR signaling in T1 vs follicular mature splenic B cells. T1, in contrast to follicular mature B cells, failed to express key NF-kappaB target genes in response to BCR engagement and exhibited a striking defect in assembly of an active transcriptional complex at the promoter of the survival and proliferative genes A1 and c-Myc. Surprisingly, and contrary to previous models, classical protein kinase C and IkappaB kinase activation, NF-kappaB nuclear translocation and DNA binding were intact in T1 B cells. Furthermore, despite a marked reduction in NFAT1 expression, differential NFAT or AP-1 activation cannot explain this transcriptional defect. Our combined findings demonstrate that T1 B cells are programmed for signal- and stage-specific "nuclear nonresponsiveness" upon encounter with self-Ags.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234182      PMCID: PMC2694130          DOI: 10.4049/jimmunol.0802368

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

Authors:  P Bouillet; D Metcalf; D C Huang; D M Tarlinton; T W Kay; F Köntgen; J M Adams; A Strasser
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

Review 2.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals.

Authors:  James B Chung; Richard A Sater; Michele L Fields; Jan Erikson; John G Monroe
Journal:  Int Immunol       Date:  2002-02       Impact factor: 4.823

4.  Unique signaling properties of B cell antigen receptor in mature and immature B cells: implications for tolerance and activation.

Authors:  R J Benschop; E Brandl; A C Chan; J C Cambier
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  BCR mediated signal transduction in immature and mature B cells.

Authors:  Gábor Koncz; Csaba Bodor; Dorottya Kövesdi; Róbert Gáti; Gabriella Sármay
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

Review 6.  Immunobiology of the immature B cell: plasticity in the B-cell antigen receptor-induced response fine tunes negative selection.

Authors:  L B King; J G Monroe
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

7.  Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development.

Authors:  Thomas T Su; David J Rawlings
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

8.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

Authors:  Haihong Zhong; Michael J May; Eijiro Jimi; Sankar Ghosh
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

9.  Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation.

Authors:  Peter R Wilker; Masako Kohyama; Michelle M Sandau; Jörn C Albring; Osamu Nakagawa; John J Schwarz; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2008-04-27       Impact factor: 25.606

10.  Two waves of nuclear factor kappaB recruitment to target promoters.

Authors:  S Saccani; S Pantano; G Natoli
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  14 in total

1.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

2.  Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.

Authors:  Sarah F Andrews; Xuezhi Dai; Byoung Y Ryu; Tod Gulick; Bindu Ramachandran; David J Rawlings
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

3.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

4.  CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells.

Authors:  Marc A Schwartz; Nikita S Kolhatkar; Chris Thouvenel; Socheath Khim; David J Rawlings
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

Review 5.  Autoreactive B cells in SLE, villains or innocent bystanders?

Authors:  Jennie A Hamilton; Hui-Chen Hsu; John D Mountz
Journal:  Immunol Rev       Date:  2019-10-21       Impact factor: 12.988

6.  A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.

Authors:  Xuezhi Dai; Richard G James; Tania Habib; Swati Singh; Shaun Jackson; Socheath Khim; Randall T Moon; Denny Liggitt; Alejandro Wolf-Yadlin; Jane H Buckner; David J Rawlings
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

Review 7.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 8.  Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.

Authors:  Subhrajit Saha; Arlene Tieng; K Peter Pepeljugoski; Gisele Zandamn-Goddard; Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 9.  Signalling crosstalk in B cells: managing worth and need.

Authors:  Michael P Cancro
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

10.  B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia.

Authors:  Hannah M Kerns; Byoung Y Ryu; Brigid V Stirling; Blythe D Sather; Alexander Astrakhan; Stephanie Humblet-Baron; Denny Liggitt; David J Rawlings
Journal:  Blood       Date:  2010-01-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.